Remi Droller - Profile and Investment Details

Investor Profile

Remi Droller is a Venture Capital, Private Equity Firm based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron, IO Biotech, Vico Therapeutics, ARGOBIO, DNA Script, STAT-Dx, Tacalyx, Synendos Therapeutics, Xeltis, ImCheck Therapeutics, Orphazyme, Sensome, Mila, Corlieve Therapeutics, Horama, Minoryx Therapeutics, Meiogenix, Safe Orthopaedics, Step Pharma, Lucine, BliNK Biomedical, ABM Pharma, Cardiologs, DeepUll, Asarina Pharma, PathoQuest, Medlumics, Alizé Pharma, BioSerenity, Vivet Therapeutics, Ermium Therapeutics, Pharvaris, Dynacure, DAMAE Medical, Stilla Technologies, OxThera. Over time, Remi Droller has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Remi Droller is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Medical Testing, CRM, Robotics, Information Technology (IT), Biotech, Medical Device, Software, Healthcare, Biotechnology, Drug Development, EdTech, Technology Transfer, Health Diagnostics, Medical, Big Data, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Remi Droller, as their portfolio suggests a familiarity and interest in this area.

Understanding Remi Droller’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.